Skip to content

Early post-resuscitation survival outcomes in patients receiving norepinephrine versus epinephrine for post-resuscitation shock in a non-trauma emergency department: a parallel-group, open-label, feasibility randomized controlled trial

Early post-resuscitation survival outcomes in patients receiving norepinephrine versus epinephrine for post-resuscitation shock in a non-trauma emergency department: a parallel-group, open-label, feasibility randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220418001
Enrollment
40
Registered
2022-04-18
Start date
2022-05-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post cardiac arrest patient who has post resuscitation shock within 1 hour after ROSC post cardiac arrest, post resuscitation shock, norepinephrine, epinephrine

Interventions

4 mg of NE diluted in 250 ml of 5% dextrose in water (concentration 16 mcg/ml) will be administered via large peripheral vein or, more preferably, central line by infusion pump. The initial infusion r
Experimental Drug,Active Comparator Drug
Norepinephrine ,Epinephrine

Sponsors

Emergency department, Siriraj hospital, Mahidol university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: We include adult patients 18 years or above who meeting all the criteria: 1. Non-traumatic cardiac arrest (one of the followings) 1.1 Out-of-hospital cardiac arrest (OHCA) - defined as pulselessness prior to arrival at the ED 1.2 Emergency department cardiac arrest (EDCA) - defined as the sudden loss of pulse in the emergency department detected by medical personnel 2. ROSC after cardiopulmonary resuscitation (CPR) - defined as return of palpable pulse or measurable blood pressure by medical personnel 3. Post-resuscitation shock within 1 hour after ROSC - defined as mean arterial pressure (MAP) less than 65 mmHg or systolic blood pressure (SBP) less than 90 mmHg by non-invasive blood pressure (NIBP) monitoring or arterial blood pressure (ABP) monitoring

Exclusion criteria

Exclusion criteria: Patients will be excluded if they have one of these following terms: 1. The cause of cardiac arrest is ST-elevation myocardial infarction (STEMI) or STEMI-equivalent myocardial infarction. In this study, we define as patients with history compatible with ischemic chest pain plus an electrocardiogram (ECG) before or after cardiac arrest that meets criteria of STEMI, or atypical ECG presentations that should prompt a primary percutaneous coronary intervention (PCI) strategy, according to 2017 European Society of Cardiology guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. These patients will be excluded for the reason that they would likely have cardiogenic shock, in which NE is preferred to EPI. 2. The diagnosis of cardiogenic shock is strongly suspected by the treating physicians or diagnosed by a consultant cardiologist. 3. The cause of cardiac arrest is anaphylaxis. 4. Patients with Do-Not-Resuscitate (DNR) order 5. Patients or legal representatives refuse vasopressors. 6. Pregnancy 7. Extracorporeal cardiopulmonary resuscitation (E-CPR) initiated before ROSC 8. Metastatic cancer or cancer patients who are currently receiving palliative treatment

Design outcomes

Primary

MeasureTime frame
The feasibility of the protocol 28 days after intervention Recruitment rate more than 8 patients per month and other feasibility outcome

Secondary

MeasureTime frame
death and re-arrest within 3 hours within 3 hours of intervention clinician's diagnosis,28-day mortality 28 days after intervention clinician's diagnosis,refractory shock rate within 3 hours ofintervention clinician's diagnosis,significant supraventricular and ventricular arrhythmias within 3 hours of intervention clinician's diagnosis,6 hour after intervention outcome within 6 hours of intervention clinician's diagnosis

Countries

Thailand

Contacts

Public ContactWasin Pansiritanachot

siriraj hospital

dr.wasinpan@gmail.com024199216

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026